These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment. Fayed N, Dávila J, Oliveros A, Medrano J, Castillo J. Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954 [Abstract] [Full Text] [Related]
8. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Calvini P, Morbelli S, De Carli F, Guerra UP, Van de Pol LA, Visser PJ. J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573 [Abstract] [Full Text] [Related]
9. Correlation of neuropsychological evaluation and SPECT imaging in patients with Alzheimer's disease. Lampl Y, Sadeh M, Laker O, Lorberboym M. Int J Geriatr Psychiatry; 2003 Apr; 18(4):288-91. PubMed ID: 12673603 [Abstract] [Full Text] [Related]
10. Correlation between neuropsychological tests and hypoperfusion in MCI patients: anatomical labeling using xjView and Talairach Daemon software. Yoon HJ, Park KW, Jeong YJ, Kang DY. Ann Nucl Med; 2012 Oct; 26(8):656-64. PubMed ID: 22777857 [Abstract] [Full Text] [Related]
14. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di Luca M, Giubbini R, Padovani A, Perani D. Neurobiol Aging; 2006 Jan; 27(1):24-31. PubMed ID: 16298237 [Abstract] [Full Text] [Related]
15. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors. Nobili F, Koulibaly M, Vitali P, Migneco O, Mariani G, Ebmeier K, Pupi A, Robert PH, Rodriguez G, Darcourt J. J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621 [Abstract] [Full Text] [Related]
16. Global dimensional complexity of multichannel EEG in mild Alzheimer's disease and age-matched cohorts. Yagyu T, Wackermann J, Shigeta M, Jelic V, Kinoshita T, Kochi K, Julin P, Almkvist O, Wahlund LO, Kondakor I, Lehmann D. Dement Geriatr Cogn Disord; 1997 Aug; 8(6):343-7. PubMed ID: 9370086 [Abstract] [Full Text] [Related]
17. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study. Garrido GE, Furuie SS, Buchpiguel CA, Bottino CM, Almeida OP, Cid CG, Camargo CH, Castro CC, Glabus MF, Busatto GF. J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):508-16. PubMed ID: 12397142 [Abstract] [Full Text] [Related]
18. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease. Vogel A, Hasselbalch SG, Gade A, Ziebell M, Waldemar G. Int J Geriatr Psychiatry; 2005 Mar; 20(3):238-46. PubMed ID: 15717342 [Abstract] [Full Text] [Related]
19. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits. Kashiwa Y, Kitabayashi Y, Narumoto J, Nakamura K, Ueda H, Fukui K. Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246 [Abstract] [Full Text] [Related]
20. Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. Nobili F, Arnaldi D, Campus C, Ferrara M, De Carli F, Brugnolo A, Dessi B, Girtler N, Morbelli S, Abruzzese G, Sambuceti G, Rodriguez G. Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2209-18. PubMed ID: 21744112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]